Thomas Hammerstrom

940 total citations
16 papers, 652 citations indexed

About

Thomas Hammerstrom is a scholar working on Management Science and Operations Research, Infectious Diseases and Statistics and Probability. According to data from OpenAlex, Thomas Hammerstrom has authored 16 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Management Science and Operations Research, 3 papers in Infectious Diseases and 3 papers in Statistics and Probability. Recurrent topics in Thomas Hammerstrom's work include Optimal Experimental Design Methods (4 papers), HIV/AIDS drug development and treatment (3 papers) and Air Quality and Health Impacts (2 papers). Thomas Hammerstrom is often cited by papers focused on Optimal Experimental Design Methods (4 papers), HIV/AIDS drug development and treatment (3 papers) and Air Quality and Health Impacts (2 papers). Thomas Hammerstrom collaborates with scholars based in United States, Netherlands and Italy. Thomas Hammerstrom's co-authors include Yi Tsong, Stacey C. FitzSimmons, Peter R. Durie, Greg A. Burkhart, Drucy Borowitz, Richard J. Grand, Albert B. Lowenfels, John D. Lloyd‐Still, Debra Birnkrant and Frederick W. Lipfert and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Statistical Association and Gastroenterology.

In The Last Decade

Thomas Hammerstrom

15 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Hammerstrom United States 10 149 134 131 129 96 16 652
George A. Davis United States 15 148 1.0× 76 0.6× 28 0.2× 122 0.9× 212 2.2× 51 885
Joseph M. Henderson United States 12 115 0.8× 12 0.1× 181 1.4× 110 0.9× 187 1.9× 22 552
Heath R Jennings United States 12 128 0.9× 52 0.4× 14 0.1× 57 0.4× 150 1.6× 15 490
Jérémie Riou France 14 101 0.7× 74 0.6× 69 0.5× 64 0.5× 64 0.7× 74 640
Agnès Saint-Raymond Netherlands 18 54 0.4× 45 0.3× 19 0.1× 39 0.3× 69 0.7× 47 767
Mark H. Mellow United States 16 61 0.4× 40 0.3× 12 0.1× 315 2.4× 628 6.5× 26 1.1k
Samir K. Shah United States 16 50 0.3× 11 0.1× 27 0.2× 363 2.8× 448 4.7× 108 892
Ajácio Brandão Brazil 17 407 2.7× 111 0.8× 444 3.4× 32 0.2× 267 2.8× 67 864
F. Fauvelle France 11 61 0.4× 43 0.3× 22 0.2× 93 0.7× 24 0.3× 38 369
G Yakupoğlu Türkiye 13 45 0.3× 17 0.1× 31 0.2× 52 0.4× 158 1.6× 39 570

Countries citing papers authored by Thomas Hammerstrom

Since Specialization
Citations

This map shows the geographic impact of Thomas Hammerstrom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Hammerstrom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Hammerstrom more than expected).

Fields of papers citing papers by Thomas Hammerstrom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Hammerstrom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Hammerstrom. The network helps show where Thomas Hammerstrom may publish in the future.

Co-authorship network of co-authors of Thomas Hammerstrom

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Hammerstrom. A scholar is included among the top collaborators of Thomas Hammerstrom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Hammerstrom. Thomas Hammerstrom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Chen, Jianmeng, Jeffry Florian, Wendy Carter, et al.. (2013). Earlier Sustained Virologic Response End Points for Regulatory Approval and Dose Selection of Hepatitis C Therapies. Gastroenterology. 144(7). 1450–1455.e2. 130 indexed citations
2.
Soon, Guoxing, Min Min, Kimberly Struble, et al.. (2012). Meta-Analysis of Gender Differences in Efficacy Outcomes for HIV-Positive Subjects in Randomized Controlled Clinical Trials of Antiretroviral Therapy (2000–2008). AIDS Patient Care and STDs. 26(8). 444–453. 56 indexed citations
3.
Liu, Jiang, Pravin Jadhav, Shashi Amur, et al.. (2012). Response-guided telaprevir therapy in prior relapsers? The role of bridging data from treatment-naïve and experienced subjects. Hepatology. 57(3). 897–902. 9 indexed citations
4.
Soon, Guoxing, Lei Nie, Thomas Hammerstrom, Wen Zeng, & Haitao Chu. (2011). Meeting the demand for more sophisticated study designs. A proposal for a new type of clinical trial: the hybrid design. BMJ Open. 1(2). e000156–e000156. 1 indexed citations
5.
Smith, F. M., Thomas Hammerstrom, Susan Zhou, et al.. (2011). A Meta-analysis to Assess the FDA DAVP’s TLOVR Algorithm in HIV Submissions. Drug Information Journal. 45(3). 291–300. 46 indexed citations
6.
Chattopadhyay, Somesh & Thomas Hammerstrom. (2008). Statistical Monitoring of Clinical Trials: A Unified Approach. Journal of the American Statistical Association. 103(481). 430–431. 3 indexed citations
7.
FitzSimmons, Stacey C., Greg A. Burkhart, Drucy Borowitz, et al.. (1997). High-Dose Pancreatic-Enzyme Supplements and Fibrosing Colonopathy in Children with Cystic Fibrosis. New England Journal of Medicine. 336(18). 1283–1289. 184 indexed citations
8.
Tsong, Yi, Thomas Hammerstrom, & James J. Chen. (1997). Multipoint dissolution specification and acceptance sampling rule based on profile modeling and principal component analysis. Journal of Biopharmaceutical Statistics. 7(3). 423–439. 35 indexed citations
9.
Wysowski, Diane K., et al.. (1996). Sedative-hypnotic drugs and the risk of hip fracture. Journal of Clinical Epidemiology. 49(1). 111–113. 24 indexed citations
10.
Brown, Nancy J., et al.. (1996). Angiotensin converting enzyme inhibitor-associated angioedema: higher risk in blacks than whites. Pharmacoepidemiology and Drug Safety. 5(3). 149–154. 34 indexed citations
11.
Tsong, Yi, Thomas Hammerstrom, Pradeep Sathe, & Vinod P. Shah. (1996). Statistical Assessment of Mean Differences between Two Dissolution Data Sets. Drug Information Journal. 30(4). 1105–1112. 68 indexed citations
12.
Tsong, Yi, et al.. (1995). Dissolution test acceptance sampling plans. Journal of Biopharmaceutical Statistics. 5(2). 171–183. 10 indexed citations
13.
Burkhart, Greg A. & Thomas Hammerstrom. (1994). The impact of clustering in physician and pharmacy services on the accuracy of pharmaceutical exposure risk estimates. Pharmacoepidemiology and Drug Safety. 3(2). 63–71.
14.
Lipfert, Frederick W. & Thomas Hammerstrom. (1992). Temporal patterns in air pollution and hospital admissions. Environmental Research. 59(2). 374–399. 41 indexed citations
15.
Hammerstrom, Thomas, et al.. (1989). Health Risks of Short-term S02Exposure to Exercising Asthmatics. JAPCA. 39(6). 831–835. 5 indexed citations
16.
Hammerstrom, Thomas. (1981). Asymptotically Optimal Tests for Heteroscedasticity in the General Linear Model. The Annals of Statistics. 9(2). 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George A. Davis Breakdown of academic impact, for papers by Joseph M. Henderson Breakdown of academic impact, for papers by Heath R Jennings Breakdown of academic impact, for papers by Jérémie Riou Breakdown of academic impact, for papers by Agnès Saint-Raymond Breakdown of academic impact, for papers by Mark H. Mellow Breakdown of academic impact, for papers by Samir K. Shah Breakdown of academic impact, for papers by Ajácio Brandão Breakdown of academic impact, for papers by F. Fauvelle Breakdown of academic impact, for papers by G Yakupoğlu
Rankless by CCL
2026